Biotechnology
Cancer
Pharmaceuticals
Unitedstates
Development
Infectious
Diseases
M&A Advisory
Lazard
Full Credential Description
Coley Pharmaceutical. United States. Announced Date 10/08/2005. Closed Date 10/08/2005. Deal value: $96m. Initial public offering. Industry: Coley Pharmaceutical is a biotechnology company focused on developing immunotherapeutic drugs for the treatment of cancer and infectious diseases.